Business Description
Biomark Diagnostics Inc
NAICS : 541380
SIC : 8681
ISIN : CA09073K1084
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | -0.42 | |||||
Debt-to-Equity | -1.94 | |||||
Debt-to-EBITDA | -1.03 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -11.13 | |||||
Beneish M-Score | -3.33 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | 2 | |||||
3-Year FCF Growth Rate | -22.4 | |||||
3-Year Book Growth Rate | -32.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 84.96 | |||||
9-Day RSI | 65.84 | |||||
14-Day RSI | 56.1 | |||||
6-1 Month Momentum % | -25 | |||||
12-1 Month Momentum % | -35.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.28 | |||||
Quick Ratio | 0.28 | |||||
Cash Ratio | 0.23 | |||||
Days Sales Outstanding | 69.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 0.9 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -999.39 | |||||
Net Margin % | -937.81 | |||||
FCF Margin % | -572.57 | |||||
ROA % | -177.97 | |||||
ROIC % | -139.8 | |||||
ROC (Joel Greenblatt) % | -232.09 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 235 | |||||
EV-to-EBIT | -15.31 | |||||
EV-to-EBITDA | -21.1 | |||||
EV-to-Revenue | 134.93 | |||||
EV-to-FCF | -23.47 | |||||
Earnings Yield (Greenblatt) % | -6.53 | |||||
FCF Yield % | -4.42 |